Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × trastuzumab deruxtecan × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 23 Neoplasm Metastasis 10 Stomach Neoplasms 6 Colorectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Brain Neoplasms 5 Ovarian Neoplasms 4 Endometrial Neoplasms 4 Salivary Gland Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 3 Adenocarcinoma 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Prostatic Neoplasms 2 Esophageal Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Thyroid Neoplasms 1 Testicular Neoplasms 1 Solid Cancer 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Mouth Neoplasms 1

Interventions

pertuzumab 2 Trastuzumab 2 tucatinib 1 pyrotinib 1 Paclitaxel 1 Fluorodeoxyglucose F18 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡